Sign in to continue:

Friday, July 31st, 2026

Day: May 12, 2026

Sagimet Biosciences Secures $175M Financing and Plans Phase 3 Denifanstat Acne Trial in 2026

Sagimet Biosciences Q1 2026 Financial Results & Corporate Up...

Antero Midstream Corporation Files Form 8-K Announcing Updated Investor Presentation – May 12, 2026

Antero Midstream Corporation Files Form 8-K: Key Takeaways f...